These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 12537982

  • 1. Masked MLL gene rearrangement was disclosed in the clinical course and sequential development of chromosome abnormality in a patient with therapy related acute myelogenous leukemia.
    Hashimoto S, Toba K, Izumi N, Sato N, Takahashi H, Ozawa T, Moriyama M, Aoki S, Furukawa T, Narita M, Takahashi M, Aizawa Y.
    Leuk Res; 2003 Mar; 27(3):285-90. PubMed ID: 12537982
    [Abstract] [Full Text] [Related]

  • 2. Clinical and biological characteristics of adult de novo and secondary acute myeloid leukemia with balanced 11q23 chromosomal anomaly or MLL gene rearrangement compared to cases with unbalanced 11q23 anomaly: confirmation of the existence of different entities with 11q23 breakpoint.
    Archimbaud E, Charrin C, Magaud JP, Campos L, Thomas X, Fière D, Rimokh R.
    Leukemia; 1998 Jan; 12(1):25-33. PubMed ID: 9436917
    [Abstract] [Full Text] [Related]

  • 3. MLL gene rearrangement in t(9;11) acute myelogenous leukemia with minimal myeloid differentiation (FAB subtype M0).
    Shimoda K, Sugio Y, Miyahara M, Watanabe K, Tokunaga Y, Asano Y, Gondo H, Okamura T, Niho Y.
    Int J Hematol; 2000 Apr; 71(3):245-8. PubMed ID: 10846829
    [Abstract] [Full Text] [Related]

  • 4. Characterization of t(11;19)(q23;p13.3) by fluorescence in situ hybridization analysis in a pediatric patient with therapy-related acute myelogenous leukemia.
    Cheng L, Ramesh KH, Radel E, Ratech H, Wei D, Cannizzaro LA.
    Cancer Genet Cytogenet; 2001 Aug; 129(1):17-22. PubMed ID: 11520560
    [Abstract] [Full Text] [Related]

  • 5. Secondary acute myelogenous leukemia with MLL gene rearrangement following radioimmunotherapy (RAIT) for non-Hodgkin's lymphoma.
    Nabhan C, Peterson LA, Kent SA, Tallman MS, Dewald G, Multani P, Gordon LI.
    Leuk Lymphoma; 2002 Nov; 43(11):2145-9. PubMed ID: 12539741
    [Abstract] [Full Text] [Related]

  • 6. Identification of complex genomic breakpoint junctions in the t(9;11) MLL-AF9 fusion gene in acute leukemia.
    Super HG, Strissel PL, Sobulo OM, Burian D, Reshmi SC, Roe B, Zeleznik-Le NJ, Diaz MO, Rowley JD.
    Genes Chromosomes Cancer; 1997 Oct; 20(2):185-95. PubMed ID: 9331569
    [Abstract] [Full Text] [Related]

  • 7. Gene rearrangements in bone marrow cells of patients with acute myelogenous leukemia.
    Schmetzer HM, Braun S, Wiesner D, Duell T, Gerhartz HH, Mittermueller J.
    Acta Haematol; 2000 Oct; 103(3):125-34. PubMed ID: 10940650
    [Abstract] [Full Text] [Related]

  • 8. Incidence of MLL rearrangement in acute myeloid leukemia, and a CALM-AF10 fusion in M4 type acute myeloblastic leukemia.
    Abdou SM, Jadayel DM, Min T, Swansbury GJ, Dainton MG, Jafer O, Powles RL, Catovsky D.
    Leuk Lymphoma; 2002 Jan; 43(1):89-95. PubMed ID: 11911106
    [Abstract] [Full Text] [Related]

  • 9. Deregulated expression of EVI1 defines a poor prognostic subset of MLL-rearranged acute myeloid leukemias: a study of the German-Austrian Acute Myeloid Leukemia Study Group and the Dutch-Belgian-Swiss HOVON/SAKK Cooperative Group.
    Gröschel S, Schlenk RF, Engelmann J, Rockova V, Teleanu V, Kühn MW, Eiwen K, Erpelinck C, Havermans M, Lübbert M, Germing U, Schmidt-Wolf IG, Beverloo HB, Schuurhuis GJ, Ossenkoppele GJ, Schlegelberger B, Verdonck LF, Vellenga E, Verhoef G, Vandenberghe P, Pabst T, Bargetzi M, Krauter J, Ganser A, Valk PJ, Löwenberg B, Döhner K, Döhner H, Delwel R.
    J Clin Oncol; 2013 Jan 01; 31(1):95-103. PubMed ID: 23008312
    [Abstract] [Full Text] [Related]

  • 10. Analysis of t(9;11) chromosomal breakpoint sequences in childhood acute leukemia: almost identical MLL breakpoints in therapy-related AML after treatment without etoposides.
    Langer T, Metzler M, Reinhardt D, Viehmann S, Borkhardt A, Reichel M, Stanulla M, Schrappe M, Creutzig U, Ritter J, Leis T, Jacobs U, Harbott J, Beck JD, Rascher W, Repp R.
    Genes Chromosomes Cancer; 2003 Apr 01; 36(4):393-401. PubMed ID: 12619163
    [Abstract] [Full Text] [Related]

  • 11. MLL rearrangement with t(6;11)(q15;q23) as a sole abnormality in a patient with de novo acute myeloid leukemia: conventional cytogenetics, FISH, and multicolor FISH analyses for detection of rare MLL-related chromosome abnormalities.
    Park TS, Lee ST, Song J, Lee KA, Lee SG, Kim J, Suh B, Kim SJ, Lee JH, Park R, Choi JR.
    Cancer Genet Cytogenet; 2008 Nov 01; 187(1):50-3. PubMed ID: 18992643
    [Abstract] [Full Text] [Related]

  • 12. Frequency and clinical significance of the MLL gene rearrangements in infant acute leukemia.
    Taki T, Ida K, Bessho F, Hanada R, Kikuchi A, Yamamoto K, Sako M, Tsuchida M, Seto M, Ueda R, Hayashi Y.
    Leukemia; 1996 Aug 01; 10(8):1303-7. PubMed ID: 8709635
    [Abstract] [Full Text] [Related]

  • 13. Secondary acute myeloid leukemia with translocation (4;11) and MLL/AF4 rearrangement in a 15-year-old boy treated for common acute lymphoblastic leukemia 11 years earlier.
    Blütters-Sawatzki R, Borkhardt A, Grathwohl J, Repp R, Rheinisch-Becker I, Bohle RM, Lampert F.
    Ann Hematol; 1995 Jan 01; 70(1):31-5. PubMed ID: 7827204
    [Abstract] [Full Text] [Related]

  • 14. Therapy-related T cell lymphoblastic lymphoma with t(11;19)(q23;p13) and MLL gene rearrangement.
    Thandla S, Alashari M, Green DM, Aplan PD.
    Leukemia; 1999 Dec 01; 13(12):2116-8. PubMed ID: 10602439
    [No Abstract] [Full Text] [Related]

  • 15. MLL-CBP fusion transcript in a therapy-related acute myeloid leukemia with the t(11;16)(q23;p13) which developed in an acute lymphoblastic leukemia patient with Fanconi anemia.
    Sugita K, Taki T, Hayashi Y, Shimaoka H, Kumazaki H, Inoue H, Konno Y, Taniwaki M, Kurosawa H, Eguchi M.
    Genes Chromosomes Cancer; 2000 Mar 01; 27(3):264-9. PubMed ID: 10679915
    [Abstract] [Full Text] [Related]

  • 16. Acute myeloid leukemia with MLL rearrangements: clinicobiological features, prognostic impact and value of flow cytometry in the detection of residual leukemic cells.
    Muñoz L, Nomdedéu JF, Villamor N, Guardia R, Colomer D, Ribera JM, Torres JP, Berlanga JJ, Fernández C, Llorente A, Queipo de Llano MP, Sánchez JM, Brunet S, Sierra J, Spanish CETLAM Group.
    Leukemia; 2003 Jan 01; 17(1):76-82. PubMed ID: 12529663
    [Abstract] [Full Text] [Related]

  • 17. A case of treatment-related myelodysplastic syndrome and acute myelogenous leukemia following high-dose chemotherapy with autologous stem cell transplantation for non-Hodgkin's lymphoma.
    Jang GD, Kim SW, Suh CW, Kim EK, Bahng HS, Jeong YH, Park IG, Kim WK, Kim SH, Suh EJ, Park CJ, Ji HS, Lee JS.
    J Korean Med Sci; 2002 Aug 01; 17(4):555-9. PubMed ID: 12172056
    [Abstract] [Full Text] [Related]

  • 18. Late-appearing MLL rearrangement arising as a secondary change in adult acute myeloid leukemia.
    Rowe D, Breese GJ, Lennard A, Bown N.
    Genes Chromosomes Cancer; 2002 May 01; 34(1):126-8. PubMed ID: 11921290
    [Abstract] [Full Text] [Related]

  • 19. Acute myelogenous leukemia with monosomy 7, inv(3) (q21q26), involving activated EVI 1 gene occurring after a complete remission of lymphoblastic lymphoma: a case report.
    Igarashi T, Shimizu S, Morishita K, Ohtsu T, Itoh K, Minami H, Fujii H, Sasaki Y, Mukai K.
    Jpn J Clin Oncol; 1998 Nov 01; 28(11):688-95. PubMed ID: 9861236
    [Abstract] [Full Text] [Related]

  • 20. Panhandle PCR strategy to amplify MLL genomic breakpoints in treatment-related leukemias.
    Megonigal MD, Rappaport EF, Jones DH, Kim CS, Nowell PC, Lange BJ, Felix CA.
    Proc Natl Acad Sci U S A; 1997 Oct 14; 94(21):11583-8. PubMed ID: 9326653
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.